The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress.

Name: The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress.
Author: Parlar, Ali

The exogenous administration of CB2 specific agonist, GW405833, inhibits inflammation by reducing cytokine production and oxidative stress. — المؤلف: Parlar, Ali — Experimental and therapeutic medicine Dec 2018

المؤلف: Parlar, Ali
النشر: Experimental and therapeutic medicine Dec 2018
الوصف: 4900-4908 p.